Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,881,224
-
Share change
-
-55,801
-
Total reported value
-
$63,039,000
-
Price per share
-
$8.00
-
Number of holders
-
27
-
Value change
-
-$968,109
-
Number of buys
-
10
-
Number of sells
-
7
Institutional Holders of ALPINE IMMUNE SCIENCES INC - COM (ALPN) as of Q1 2018
As of 31 Mar 2018,
ALPINE IMMUNE SCIENCES INC - COM (ALPN) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,881,224 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BVF INC/IL, VANGUARD GROUP INC, TIGER MANAGEMENT L.L.C., RENAISSANCE TECHNOLOGIES LLC, VICTORY CAPITAL MANAGEMENT INC, BRIDGEWAY CAPITAL MANAGEMENT INC, and DEUTSCHE BANK AG\.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.